Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07197580 |
| Title | Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC (LUTEON) |
| Acronym | LUTEON |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Telix Pharmaceuticals (Innovations) Pty Limited |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |